~~<i id='1DD9E214C0'><strike id='1DD9E214C0'><tt id='1DD9E214C0'><pre id='1DD9E214C0'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

knowledge

author：hotspot 2025-09-09 05:35:25 - browse：1485

Eli Lilly said Friday that it will acquire Dermira, a small biotech developing drugs for chronic skin conditions, for $1.1 billion.

The centerpiece of the deal is the Dermira drug called lebrikizumab that aims to treat people suffering from moderate-to-severe atopic dermatitis, the most common form of eczema, a disease characterized by inflamed, itchy, and scaly skin.

Phase 3 clinical trials of lebrikizumab in atopic dermatitis are underway. If successful, the drug could compete against Dupixent, which has grown into a commercial blockbuster for Regeneron Pharmaceuticals and Sanofi.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： Why Novartis is changing the name of its research labs

hotspot

Wikipedia

entertainment

hotspot

entertainment

knowledge

AdobeTheCanadiansurgeonandurologistBalfourMountisconsideredthefatherofpalliativecareinNorthAmerica.H

WSS

Medicare inequities exacerbate Puerto Rico’s health disparities

Crinetics acromegaly drug succeeds in late

Alabama IVF ruling threatens families facing fatal genetic disease

Ed Silverman on new gene therapies, biosimilars, coffee, and more

Why palliative psychiatry is worth discussing

Readout Newsletter: Alnylam, Celldex, Roche, Zealand Pharma

hotspot

knowledge

hotspot

Tori Bowie and the unacceptable rates of Black maternal death

Ethical issues complicate the benefits of medical crowdfunding

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Cyberattack on UnitedHealth subsidiary cripples pharmacies, hospitals

Medicare proposal to cover medical devices draws a mixed reaction

Snackable artificial intelligence, expert AI, and the pharma industry

Peter Hotez and the public health issue of online harassment

House transparency, PBM reform bill gains bipartisan support

Sports medicine is finally prioritizing gender equality

Biotech execs pursue obesity drug boom: ‘It’s the early innings’

Wikipedia

Cyberattack on UnitedHealth subsidiary cripples pharmacies, hospitals

Trump surgeon general acknowledges mistakes during Covid

Community Health Systems hospitals under DOJ investigation

Covid hospitalizations on the rise, Humana says

A new nitrogen execution bill also undermines medical licensing

PBM reform efforts get punted in Congress

entertainment

hotspot

entertainment

knowledge